Clinical trial
Bone Response to Enzyme Replacement in Gaucher's Disease
NCT00001416 · National Institute of Neurological Disorders and Stroke (NINDS), NIH · Completed
Key facts
| NCT number | NCT00001416 |
|---|---|
| Title | Bone Response to Enzyme Replacement in Gaucher's Disease |
| Official title | Skeletal Responses to Macrophage-Targeted Glucocerebrosidase in Patients With Type 1 Gaucher's Disease |
| Lead sponsor | National Institute of Neurological Disorders and Stroke (NINDS), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Gaucher's Disease |
| Intervention type | Drug |
| Interventions | CEREDASE™ |
| Enrollment | 100 |
| Start date | Dec 1, 1993 |
| Completion | Nov 1, 2000 |
| First posted | Dec 10, 2002 |
| Last update posted | Sep 22, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: